{
    "title": "Hikma to buy Boehringer's U.S. generic drug business for $2.65 bln",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-3176990/Hikma-buy-Boehringers-U-S-generics-unit-2-65-bln.html",
    "date": "2015-07-28",
    "keywords": [
        "boehringer",
        "deal",
        "business",
        "sector",
        "percent",
        "hikma",
        "drug",
        "company",
        "share",
        "gmt",
        "july",
        "cash",
        "stock",
        "size",
        "purchase",
        "index",
        "inc",
        "price",
        "bln",
        "email",
        "aastha",
        "agnihotri",
        "string",
        "edgethe",
        "jordanian",
        "generic",
        "provider",
        "statesthe",
        "day",
        "tevas",
        "rank",
        "scale",
        "companieshikma",
        "half",
        "germanys",
        "yearhowever",
        "medicine",
        "market",
        "stateswe",
        "wont",
        "teva",
        "executive",
        "pence",
        "tuesday",
        "ftse100",
        "inclusion",
        "year",
        "pfizer",
        "hospira",
        "endo",
        "offer",
        "perrigo",
        "companyindias",
        "lupin",
        "gavis",
        "monththe",
        "division",
        "bringing",
        "capital",
        "roxane",
        "note",
        "valuation",
        "issue",
        "exchange",
        "rate",
        "pound",
        "milestone",
        "part",
        "quarter",
        "yearhikma",
        "acquisition",
        "race",
        "number",
        "moment",
        "darwazah",
        "david",
        "clarke"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}